Details for: NINJ1

Gene ID: 4814

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: NINJ1

Ensembl ID: ENSG00000131669

Description: ninjurin 1

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • CD14-low, CD16-positive monocyte CL0002396
    CSI 44.14
    rCSI 34.01%
    PRS 68.71
  • myeloid leukocyte CL0000766
    CSI 43.58
    rCSI 40.21%
    PRS 69.2
  • Hofbauer cell CL3000001
    CSI 36.64
    rCSI 69.17%
    PRS 77.56
  • alternatively activated macrophage CL0000890
    CSI 19.72
    rCSI 24.8%
    PRS 78.75
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 18.13
    rCSI 23.76%
    PRS 80.41
  • non-classical monocyte CL0000875
    CSI 15.31
    rCSI 24.54%
    PRS 85.47
  • ionocyte CL0005006
    CSI 14.32
    rCSI 15.35%
    PRS 67.55
  • macrophage CL0000235
    CSI 13.85
    rCSI 25.2%
    PRS 81.21
  • elicited macrophage CL0000861
    CSI 12.98
    rCSI 11.92%
    PRS 76.4
  • group 3 innate lymphoid cell CL0001071
    CSI 12.65
    rCSI 9.5%
    PRS 73.2
  • intestinal epithelial cell CL0002563
    CSI 12.05
    rCSI 12.6%
    PRS 65.25
  • plasmacytoid dendritic cell, human CL0001058
    CSI 11.66
    rCSI 8.14%
    PRS 70.28
  • mononuclear phagocyte CL0000113
    CSI 11.49
    rCSI 25.29%
    PRS 71.43
  • plasmablast CL0000980
    CSI 11.38
    rCSI 8.95%
    PRS 73.87
  • extravillous trophoblast CL0008036
    CSI 11.09
    rCSI 13.72%
    PRS 64.23
  • colon macrophage CL0009038
    CSI 10.24
    rCSI 47.3%
    PRS 84.19
  • T follicular helper cell CL0002038
    CSI 10.18
    rCSI 7.62%
    PRS 81.9
  • respiratory basal cell CL0002633
    CSI 10.05
    rCSI 10.41%
    PRS 73.19
  • enterocyte CL0000584
    CSI 9.87
    rCSI 15.92%
    PRS 69.66
  • melanocyte CL0000148
    CSI 9.87
    rCSI 7.31%
    PRS 60.15
  • granulocyte CL0000094
    CSI 8.03
    rCSI 12.27%
    PRS 76.44
  • secretory cell CL0000151
    CSI 7.9
    rCSI 8.24%
    PRS 67.32
  • early lymphoid progenitor CL0000936
    CSI 7.73
    rCSI 6.79%
    PRS 72.74
  • dendritic cell CL0000451
    CSI 7.66
    rCSI 9.44%
    PRS 78.05
  • colon epithelial cell CL0011108
    CSI 7.6
    rCSI 7.96%
    PRS 64.04
  • ciliated cell CL0000064
    CSI 7.52
    rCSI 12.18%
    PRS 63.35
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 7.37
    rCSI 14.69%
    PRS 83.36
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 7.36
    rCSI 19.03%
    PRS 62.3
  • pancreatic ductal cell CL0002079
    CSI 7.35
    rCSI 14.3%
    PRS 70.42
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 7.31
    rCSI 44.25%
    PRS 84.01
  • endothelial cell of lymphatic vessel CL0002138
    CSI 7
    rCSI 13.87%
    PRS 78.98
  • mature NK T cell CL0000814
    CSI 6.74
    rCSI 8.62%
    PRS 85.03
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 6.71
    rCSI 8.11%
    PRS 76.26
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 6.62
    rCSI 6.51%
    PRS 82.71
  • keratinocyte CL0000312
    CSI 6.54
    rCSI 5.48%
    PRS 71.09
  • myofibroblast cell CL0000186
    CSI 6.18
    rCSI 8.56%
    PRS 67.18
  • intrahepatic cholangiocyte CL0002538
    CSI 6.14
    rCSI 14.73%
    PRS 75.77
  • promyelocyte CL0000836
    CSI 6.1
    rCSI 8.79%
    PRS 75.77
  • Langerhans cell CL0000453
    CSI 6.09
    rCSI 9.3%
    PRS 81.88
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 6.09
    rCSI 4.37%
    PRS 81.3
  • dendritic cell, human CL0001056
    CSI 5.99
    rCSI 9.2%
    PRS 76.66
  • skin fibroblast CL0002620
    CSI 5.94
    rCSI 5.12%
    PRS 71.51
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 5.9
    rCSI 15.39%
    PRS 67.39
  • intestine goblet cell CL0019031
    CSI 5.87
    rCSI 5.21%
    PRS 65.09
  • Kupffer cell CL0000091
    CSI 5.52
    rCSI 12.63%
    PRS 67.75
  • conventional dendritic cell CL0000990
    CSI 5.48
    rCSI 4.57%
    PRS 74.87
  • respiratory suprabasal cell CL4033048
    CSI 5.47
    rCSI 7.02%
    PRS 71.82
  • CD4-positive helper T cell CL0000492
    CSI 5.32
    rCSI 4.03%
    PRS 80.8
  • activated type II NK T cell CL0000931
    CSI 5.22
    rCSI 5.87%
    PRS 83.35
  • mesenchymal cell CL0008019
    CSI 5.17
    rCSI 13.14%
    PRS 61.21
  • lung secretory cell CL1000272
    CSI 5.1
    rCSI 12.63%
    PRS 66.09
  • monocyte CL0000576
    CSI 5.04
    rCSI 9.1%
    PRS 78.84
  • naive T cell CL0000898
    CSI 5
    rCSI 3.48%
    PRS 82.48
  • hepatocyte CL0000182
    CSI 4.99
    rCSI 8.93%
    PRS 66.86
  • fibroblast of lung CL0002553
    CSI 4.76
    rCSI 4.43%
    PRS 68.07
  • pulmonary ionocyte CL0017000
    CSI 4.72
    rCSI 5.75%
    PRS 74.82
  • neutrophil CL0000775
    CSI 4.69
    rCSI 26.25%
    PRS 72.42
  • pancreatic acinar cell CL0002064
    CSI 4.59
    rCSI 6.11%
    PRS 73.61
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 4.52
    rCSI 3.62%
    PRS 85.83
  • lung macrophage CL1001603
    CSI 4.47
    rCSI 9.98%
    PRS 75.06
  • promonocyte CL0000559
    CSI 4.44
    rCSI 7.61%
    PRS 75.51
  • chondrocyte CL0000138
    CSI 4.4
    rCSI 7%
    PRS 60.05
  • CD14-positive monocyte CL0001054
    CSI 4.03
    rCSI 5.02%
    PRS 78.02
  • acinar cell CL0000622
    CSI 4
    rCSI 5.86%
    PRS 78.59
  • precursor B cell CL0000817
    CSI 3.92
    rCSI 3.44%
    PRS 76.24
  • double negative thymocyte CL0002489
    CSI 3.82
    rCSI 2.66%
    PRS 78.88
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 3.8
    rCSI 4.87%
    PRS 64.1
  • lung interstitial macrophage CL4033043
    CSI 3.79
    rCSI 8.5%
    PRS 83.13
  • fallopian tube secretory epithelial cell CL4030006
    CSI 3.73
    rCSI 3.59%
    PRS 67.11
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 3.56
    rCSI 6.08%
    PRS 83.88
  • M cell of gut CL0000682
    CSI 3.56
    rCSI 3.78%
    PRS 75.9
  • myoepithelial cell CL0000185
    CSI 3.39
    rCSI 8.58%
    PRS 74.78
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 3.27
    rCSI 2.48%
    PRS 80.5
  • stem cell CL0000034
    CSI 3.19
    rCSI 3.07%
    PRS 58.67
  • pro-B cell CL0000826
    CSI 3.18
    rCSI 2.63%
    PRS 69.76
  • mammary gland epithelial cell CL0002327
    CSI 3.17
    rCSI 11.13%
    PRS 78.65
  • colonocyte CL1000347
    CSI 3.17
    rCSI 4.54%
    PRS 70.07
  • enteroendocrine cell CL0000164
    CSI 3.12
    rCSI 4.26%
    PRS 68.38
  • placental villous trophoblast CL2000060
    CSI 3.09
    rCSI 4.78%
    PRS 65.86
  • goblet cell CL0000160
    CSI 3.05
    rCSI 2.88%
    PRS 66.41
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 2.89
    rCSI 8.28%
    PRS 86.36
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 2.86
    rCSI 4.47%
    PRS 88.54
  • bronchial goblet cell CL1000312
    CSI 2.82
    rCSI 11.26%
    PRS 80.74
  • natural T-regulatory cell CL0000903
    CSI 2.81
    rCSI 5.32%
    PRS 92.14
  • epithelial cell of lower respiratory tract CL0002632
    CSI 2.79
    rCSI 2.17%
    PRS 70.31
  • bronchus fibroblast of lung CL2000093
    CSI 2.76
    rCSI 2.24%
    PRS 67.78
  • pulmonary capillary endothelial cell CL4028001
    CSI 2.7
    rCSI 5.14%
    PRS 81.02
  • respiratory hillock cell CL4030023
    CSI 2.67
    rCSI 4.76%
    PRS 79.76
  • blood vessel endothelial cell CL0000071
    CSI 2.65
    rCSI 5.49%
    PRS 64.41
  • radial glial cell CL0000681
    CSI 2.61
    rCSI 3.63%
    PRS 66.08
  • interstitial cell of Cajal CL0002088
    CSI 2.6
    rCSI 3.31%
    PRS 73.55
  • luminal epithelial cell of mammary gland CL0002326
    CSI 2.51
    rCSI 4.57%
    PRS 81.29
  • perivascular cell CL4033054
    CSI 2.49
    rCSI 3.4%
    PRS 73.17
  • club cell CL0000158
    CSI 2.48
    rCSI 3.63%
    PRS 62.5
  • neural crest cell CL0011012
    CSI 2.45
    rCSI 1.93%
    PRS 54.45
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.44
    rCSI 1.65%
    PRS 80.93
  • glioblast CL0000030
    CSI 2.41
    rCSI 3.84%
    PRS 59.57
  • innate lymphoid cell CL0001065
    CSI 2.37
    rCSI 4.9%
    PRS 67.54
  • myeloid dendritic cell CL0000782
    CSI 2.35
    rCSI 3.4%
    PRS 82.56
  • ciliated epithelial cell CL0000067
    CSI 2.35
    rCSI 2.06%
    PRS 55.28
  • acinar cell of salivary gland CL0002623
    CSI 0.1
    rCSI 2.8%
    PRS 83.9%
  • prostate gland microvascular endothelial cell CL2000059
    CSI 0.3
    rCSI 6.2%
    PRS 82.5%
  • hair follicular keratinocyte CL2000092
    CSI 0.3
    rCSI 4.8%
    PRS 85.1%
  • pancreatic stellate cell CL0002410
    CSI 0.5
    rCSI 2.7%
    PRS 75.0%
  • type EC enteroendocrine cell CL0000577
    CSI 0.5
    rCSI 1.7%
    PRS 74.6%
  • basal cell of epithelium of trachea CL1000348
    CSI 0.5
    rCSI 3.4%
    PRS 78.9%
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 0.5
    rCSI 5.3%
    PRS 84.1%
  • podocyte CL0000653
    CSI 0.5
    rCSI 2.2%
    PRS 67.5%
  • tracheobronchial serous cell CL0019001
    CSI 0.5
    rCSI 2.2%
    PRS 78.5%
  • eosinophil CL0000771
    CSI 0.6
    rCSI 4.1%
    PRS 90.7%
  • endothelial cell of placenta CL0009092
    CSI 0.7
    rCSI 3.6%
    PRS 77.9%
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 0.8
    rCSI 3.5%
    PRS 90.5%
  • megakaryocyte CL0000556
    CSI 0.8
    rCSI 3.5%
    PRS 77.8%
  • late pro-B cell CL0002048
    CSI 0.9
    rCSI 2.2%
    PRS 88.0%
  • fibroblast of breast CL4006000
    CSI 0.9
    rCSI 3.7%
    PRS 78.1%
  • large pre-B-II cell CL0000957
    CSI 0.9
    rCSI 2.5%
    PRS 77.3%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 1.0
    rCSI 4.8%
    PRS 80.0%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 1.0
    rCSI 0.9%
    PRS 64.6%
  • cytotoxic T cell CL0000910
    CSI 1.1
    rCSI 6.2%
    PRS 75.3%
  • common myeloid progenitor CL0000049
    CSI 1.2
    rCSI 0.9%
    PRS 69.2%
  • myeloid dendritic cell, human CL0001057
    CSI 1.2
    rCSI 6.9%
    PRS 86.9%
  • retinal ganglion cell CL0000740
    CSI 1.2
    rCSI 2.7%
    PRS 53.2%
  • common dendritic progenitor CL0001029
    CSI 1.3
    rCSI 1.6%
    PRS 77.7%
  • respiratory epithelial cell CL0002368
    CSI 1.3
    rCSI 7.9%
    PRS 90.4%
  • kidney collecting duct principal cell CL1001431
    CSI 1.3
    rCSI 6.6%
    PRS 66.6%
  • microcirculation associated smooth muscle cell CL0008035
    CSI 1.4
    rCSI 3.9%
    PRS 68.3%
  • basal cell of epidermis CL0002187
    CSI 1.4
    rCSI 2.4%
    PRS 39.7%
  • alveolar macrophage CL0000583
    CSI 1.4
    rCSI 2.4%
    PRS 72.7%
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 1.4
    rCSI 1.4%
    PRS 86.1%
  • luminal cell of prostate epithelium CL0002340
    CSI 1.5
    rCSI 8.1%
    PRS 77.9%
  • basal cell of prostate epithelium CL0002341
    CSI 1.5
    rCSI 4.4%
    PRS 77.7%
  • fraction A pre-pro B cell CL0002045
    CSI 1.6
    rCSI 1.9%
    PRS 83.7%
  • lung ciliated cell CL1000271
    CSI 1.7
    rCSI 2.0%
    PRS 58.1%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 1.8
    rCSI 1.6%
    PRS 72.2%
  • mesodermal cell CL0000222
    CSI 1.8
    rCSI 2.2%
    PRS 65.5%
  • intermediate monocyte CL0002393
    CSI 1.8
    rCSI 2.8%
    PRS 72.3%
  • kidney epithelial cell CL0002518
    CSI 1.9
    rCSI 3.6%
    PRS 85.1%
  • mucous neck cell CL0000651
    CSI 1.9
    rCSI 2.7%
    PRS 76.9%
  • transit amplifying cell of colon CL0009011
    CSI 1.9
    rCSI 2.3%
    PRS 69.4%
  • enteric smooth muscle cell CL0002504
    CSI 1.9
    rCSI 2.8%
    PRS 69.3%
  • platelet CL0000233
    CSI 1.9
    rCSI 8.0%
    PRS 68.8%
  • microglial cell CL0000129
    CSI 1.9
    rCSI 7.8%
    PRS 70.8%
  • erythrocyte CL0000232
    CSI 2.0
    rCSI 4.5%
    PRS 70.1%
  • hematopoietic stem cell CL0000037
    CSI 2.0
    rCSI 1.3%
    PRS 70.3%
  • mature alpha-beta T cell CL0000791
    CSI 2.0
    rCSI 7.1%
    PRS 85.8%
  • epithelial cell of lung CL0000082
    CSI 2.0
    rCSI 1.7%
    PRS 67.0%
  • nasal mucosa goblet cell CL0002480
    CSI 2.1
    rCSI 2.4%
    PRS 74.2%
  • group 2 innate lymphoid cell CL0001069
    CSI 2.1
    rCSI 11.4%
    PRS 91.1%
  • vascular associated smooth muscle cell CL0000359
    CSI 2.2
    rCSI 7.1%
    PRS 66.8%
  • epithelial cell of proximal tubule CL0002306
    CSI 2.2
    rCSI 5.3%
    PRS 60.4%
  • duct epithelial cell CL0000068
    CSI 2.2
    rCSI 3.2%
    PRS 72.2%
  • mucus secreting cell CL0000319
    CSI 2.2
    rCSI 3.5%
    PRS 77.8%
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 2.2
    rCSI 3.1%
    PRS 89.5%
  • multi-ciliated epithelial cell CL0005012
    CSI 2.3
    rCSI 2.3%
    PRS 60.8%
  • T-helper 17 cell CL0000899
    CSI 2.3
    rCSI 1.8%
    PRS 87.3%
  • inflammatory macrophage CL0000863
    CSI 2.3
    rCSI 3.9%
    PRS 87.7%
  • lung endothelial cell CL1001567
    CSI 2.3
    rCSI 5.4%
    PRS 83.6%
  • ciliated epithelial cell CL0000067
    CSI 2.4
    rCSI 2.1%
    PRS 55.3%
  • myeloid dendritic cell CL0000782
    CSI 2.4
    rCSI 3.4%
    PRS 82.6%
  • innate lymphoid cell CL0001065
    CSI 2.4
    rCSI 4.9%
    PRS 67.5%
  • glioblast CL0000030
    CSI 2.4
    rCSI 3.8%
    PRS 59.6%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.4
    rCSI 1.7%
    PRS 80.9%
  • neural crest cell CL0011012
    CSI 2.5
    rCSI 1.9%
    PRS 54.5%
  • club cell CL0000158
    CSI 2.5
    rCSI 3.6%
    PRS 62.5%
  • perivascular cell CL4033054
    CSI 2.5
    rCSI 3.4%
    PRS 73.2%
  • luminal epithelial cell of mammary gland CL0002326
    CSI 2.5
    rCSI 4.6%
    PRS 81.3%
  • interstitial cell of Cajal CL0002088
    CSI 2.6
    rCSI 3.3%
    PRS 73.6%
  • radial glial cell CL0000681
    CSI 2.6
    rCSI 3.6%
    PRS 66.1%
  • blood vessel endothelial cell CL0000071
    CSI 2.7
    rCSI 5.5%
    PRS 64.4%
  • respiratory hillock cell CL4030023
    CSI 2.7
    rCSI 4.8%
    PRS 79.8%
  • pulmonary capillary endothelial cell CL4028001
    CSI 2.7
    rCSI 5.1%
    PRS 81.0%
  • bronchus fibroblast of lung CL2000093
    CSI 2.8
    rCSI 2.2%
    PRS 67.8%
  • epithelial cell of lower respiratory tract CL0002632
    CSI 2.8
    rCSI 2.2%
    PRS 70.3%
  • natural T-regulatory cell CL0000903
    CSI 2.8
    rCSI 5.3%
    PRS 92.1%
  • bronchial goblet cell CL1000312
    CSI 2.8
    rCSI 11.3%
    PRS 80.7%
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 2.9
    rCSI 4.5%
    PRS 88.5%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 2.9
    rCSI 8.3%
    PRS 86.4%
  • goblet cell CL0000160
    CSI 3.1
    rCSI 2.9%
    PRS 66.4%
  • placental villous trophoblast CL2000060
    CSI 3.1
    rCSI 4.8%
    PRS 65.9%
  • enteroendocrine cell CL0000164
    CSI 3.1
    rCSI 4.3%
    PRS 68.4%
  • colonocyte CL1000347
    CSI 3.2
    rCSI 4.5%
    PRS 70.1%
  • mammary gland epithelial cell CL0002327
    CSI 3.2
    rCSI 11.1%
    PRS 78.7%
  • pro-B cell CL0000826
    CSI 3.2
    rCSI 2.6%
    PRS 69.8%
  • stem cell CL0000034
    CSI 3.2
    rCSI 3.1%
    PRS 58.7%
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 3.3
    rCSI 2.5%
    PRS 80.5%
  • myoepithelial cell CL0000185
    CSI 3.4
    rCSI 8.6%
    PRS 74.8%
  • M cell of gut CL0000682
    CSI 3.6
    rCSI 3.8%
    PRS 75.9%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 3.6
    rCSI 6.1%
    PRS 83.9%
  • fallopian tube secretory epithelial cell CL4030006
    CSI 3.7
    rCSI 3.6%
    PRS 67.1%
  • lung interstitial macrophage CL4033043
    CSI 3.8
    rCSI 8.5%
    PRS 83.1%
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 3.8
    rCSI 4.9%
    PRS 64.1%
  • double negative thymocyte CL0002489
    CSI 3.8
    rCSI 2.7%
    PRS 78.9%
  • precursor B cell CL0000817
    CSI 3.9
    rCSI 3.4%
    PRS 76.2%
  • acinar cell CL0000622
    CSI 4.0
    rCSI 5.9%
    PRS 78.6%
  • CD14-positive monocyte CL0001054
    CSI 4.0
    rCSI 5.0%
    PRS 78.0%
  • chondrocyte CL0000138
    CSI 4.4
    rCSI 7.0%
    PRS 60.1%
  • promonocyte CL0000559
    CSI 4.4
    rCSI 7.6%
    PRS 75.5%
  • lung macrophage CL1001603
    CSI 4.5
    rCSI 10.0%
    PRS 75.1%
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 4.5
    rCSI 3.6%
    PRS 85.8%
  • pancreatic acinar cell CL0002064
    CSI 4.6
    rCSI 6.1%
    PRS 73.6%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [NINJ1](/details-gene/4814) (Ninjurin 1) is a protein-coding gene located on chromosome 9q22.31 that encodes a homophilic cell adhesion molecule. Initially identified for its role in promoting axonal growth following nerve injury ([Link](https://doi.org/10.1016/s0896-6273(00)80166-x)), its function has been significantly expanded. More recent evidence has established [NINJ1](/details-gene/4814) as a critical executioner of plasma membrane rupture during various forms of lytic cell death, including pyroptosis, necroptosis, and ferroptosis ([Link](https://doi.org/10.1038/s41586-021-03218-7), [Link](https://doi.org/10.1038/s44318-024-00055-y)). This function is central to inflammatory processes and the release of damage-associated molecular patterns (DAMPs). Consistent with its role in inflammation and cell death, [NINJ1](/details-gene/4814) shows high significance in various [myeloid leukocytes](/details-cell/CL0000766), particularly [monocyte](/details-cell/CL0002396) and [macrophage](/details-cell/CL0000235) populations. Clinically, it has been mapped to the candidate region for hereditary sensory neuropathy type I ([OMIM: 602062](https://omim.org/entry/602062)) ([Link](https://doi.org/10.1006/geno.1997.5084)). ## Cellular Roles and Expression Landscape The expression profile of [NINJ1](/details-gene/4814) strongly implicates it as a key effector molecule within the innate immune system, particularly in the mononuclear phagocyte lineage. **Overall**, the gene exhibits its highest significance in [myeloid leukocyte](/details-cell/CL0000766) populations. It is a top marker for [CD14-low, CD16-positive monocytes](/details-cell/CL0002396) (CSI: 44.14), also known as [non-classical monocytes](/details-cell/CL0000875), which are involved in patrolling blood vessels and responding to inflammation. High significance is also observed across various [macrophage](/details-cell/CL0000235) subtypes, including specialized placental [Hofbauer cells](/details-cell/CL3000001), [alternatively activated macrophages](/details-cell/CL0000890), and [elicited macrophages](/details-cell/CL0000861). This broad and high expression across the monocyte-macrophage axis suggests a fundamental role in their function, likely related to inflammatory responses, tissue remodeling, and the execution of cell death programs. Beyond the core myeloid compartment, [NINJ1](/details-gene/4814) also shows significant expression in other immune cells, including [group 3 innate lymphoid cells](/details-cell/CL0001071), [plasmacytoid dendritic cells, human](/details-cell/CL0001058), and [plasmablasts](/details-cell/CL0000980). Its notable significance in non-immune cells such as [intestinal epithelial cells](/details-cell/CL0002563) and placental [extravillous trophoblasts](/details-cell/CL0008036) suggests a broader role in tissue homeostasis, barrier integrity, and cellular turnover, particularly in environments exposed to stress or injury. ## Pathways and Molecular Function Functional annotations for [NINJ1](/details-gene/4814) reveal a dual role, encompassing both its originally described adhesion functions and its more recently discovered role as a key mediator of lytic cell death. The primary and most critical function of [NINJ1](/details-gene/4814) appears to be its direct involvement in the final, catastrophic step of lytic cell death. It possesses [Membrane destabilizing activity](/details-go/GO:0140912) and is a central component of pathways such as [Pyroptotic cell death](/details-go/GO:0141201), [Ferroptosis](/details-go/GO:0097707), and general [Programmed necrotic cell death](/details-go/GO:0097300). By oligomerizing and rupturing the plasma membrane, it facilitates [Cytolysis](/details-go/GO:0019835), leading to the release of inflammatory mediators ([Link](https://doi.org/10.1038/s41586-021-03218-7)). This mechanism directly links the gene to the [Inflammatory response](/details-go/GO:0006954), consistent with its high expression in myeloid cells. Its ability to bind lipopolysaccharide ([Lipopolysaccharide binding](/details-go/GO:0001530)) further solidifies its role in sensing and responding to bacterial pathogens ([Link](https://doi.org/10.3892/ijo.2015.3296)). Concurrent with its cell death function, [NINJ1](/details-gene/4814) acts as a cell surface protein involved in [Cell adhesion](/details-go/GO:0007155) and [Protein homooligomerization](/details-go/GO:0051260) ([Link](https://doi.org/10.1074/jbc.272.34.21373)). This adhesion role is crucial for processes like [Leukocyte chemotaxis involved in inflammatory response](/details-go/GO:0002232) and the migration of myeloid cells into inflamed tissues ([Link](https://doi.org/10.1002/ana.22519)). Its involvement in [Angiogenesis](/details-go/GO:0001525) ([Link](https://doi.org/10.1038/s41598-020-73340-5)) and [Nervous system development](/details-go/GO:0007399) reflects its broader roles in tissue development, repair, and regeneration. ## Research Directions The central role of [NINJ1](/details-gene/4814) as an executioner of lytic cell death across multiple pathways positions it as a critical nexus in inflammation and tissue injury. Future research should focus on its precise regulatory mechanisms and its pathological contributions in specific disease contexts. ### Proposed Hypotheses: 1. **Hypothesis:** The high significance of [NINJ1](/details-gene/4814) in [macrophages](/details-cell/CL0000235) suggests it is a key driver of necrotic core formation in atherosclerosis. Its activity likely mediates macrophage pyroptosis or ferroptosis in response to lipid overload and oxidative stress, leading to plaque instability. 2. **Hypothesis:** In the context of neuroinflammation, such as in multiple sclerosis or traumatic brain injury, upregulation of [NINJ1](/details-gene/4814) on infiltrating [myeloid leukocytes](/details-cell/CL0000766) and resident microglia is a primary cause of non-specific neuronal and oligodendrocyte damage through bystander lytic cell death. ### Key Experimental Approach: To test the role of [NINJ1](/details-gene/4814) in neuroinflammation (Hypothesis 2), the experimental autoimmune encephalomyelitis (EAE) mouse model of multiple sclerosis could be utilized. Myeloid-specific conditional knockout mice (*Ninj1* fl/fl; Lyz2-Cre) would be subjected to EAE induction. The clinical disease score, immune cell infiltration into the central nervous system (analyzed by flow cytometry), and the extent of demyelination and axonal damage (assessed by histology) would be compared between knockout and wild-type control mice. This would directly test whether NINJ1-mediated lysis by infiltrating myeloid cells is required for EAE pathology. ### Therapeutic Potential: [NINJ1](/details-gene/4814) represents a highly promising therapeutic target for a wide range of inflammatory and ischemic diseases. As a [Plasma membrane](/details-go/GO:0005886) protein, it is readily accessible to antibody-based therapies. The therapeutic strategy would be **inhibition** to prevent plasma membrane rupture. Blocking [NINJ1](/details-gene/4814) function could serve as a "cell death checkpoint inhibitor," limiting the release of DAMPs and subsequent sterile inflammation. This approach could be beneficial in conditions characterized by excessive lytic cell death, such as sepsis, myocardial infarction, stroke, and acute kidney injury. A recent study has already demonstrated that inhibitory antibodies against [NINJ1](/details-gene/4814) can limit tissue injury in mouse models, validating this therapeutic concept ([Link](https://doi.org/10.1038/s41586-023-06191-5)).

Genular Protein ID: 4070870751

Symbol: NINJ1_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 8780658

Title: Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth.

PubMed ID: 8780658

DOI: 10.1016/s0896-6273(00)80166-x

PubMed ID: 9465296

Title: The human homologue of the ninjurin gene maps to the candidate region of hereditary sensory neuropathy type I (HSNI).

PubMed ID: 9465296

DOI: 10.1006/geno.1997.5084

PubMed ID: 15164053

Title: DNA sequence and analysis of human chromosome 9.

PubMed ID: 15164053

DOI: 10.1038/nature02465

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 9261151

Title: Mechanism of homophilic binding mediated by ninjurin, a novel widely expressed adhesion molecule.

PubMed ID: 9261151

DOI: 10.1074/jbc.272.34.21373

PubMed ID: 22162058

Title: Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions.

PubMed ID: 22162058

DOI: 10.1002/ana.22519

PubMed ID: 22814378

Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

PubMed ID: 22814378

DOI: 10.1073/pnas.1210303109

PubMed ID: 26677008

Title: Ninjurin1 regulates lipopolysaccharide-induced inflammation through direct binding.

PubMed ID: 26677008

DOI: 10.3892/ijo.2015.3296

PubMed ID: 32883094

Title: Anti-inflammatory actions of soluble ninjurin-1 ameliorate atherosclerosis.

PubMed ID: 32883094

DOI: 10.1161/circulationaha.120.046907

PubMed ID: 32147432

Title: Ninjurin-1 upregulated by TNFalpha receptor 1 stimulates monocyte adhesion to human TNFalpha-activated endothelial cells; benefic effects of amlodipine.

PubMed ID: 32147432

DOI: 10.1016/j.lfs.2020.117518

PubMed ID: 33028854

Title: Ninjurin 1 dodecamer peptide containing the N-terminal adhesion motif (N-NAM) exerts proangiogenic effects in HUVECs and in the postischemic brain.

PubMed ID: 33028854

DOI: 10.1038/s41598-020-73340-5

PubMed ID: 33472215

Title: NINJ1 mediates plasma membrane rupture during lytic cell death.

PubMed ID: 33472215

DOI: 10.1038/s41586-021-03218-7

PubMed ID: 36468682

Title: Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death.

PubMed ID: 36468682

DOI: 10.7554/elife.78609

PubMed ID: 37196676

Title: Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury.

PubMed ID: 37196676

DOI: 10.1038/s41586-023-06191-5

PubMed ID: 38396301

Title: NINJ1 induces plasma membrane rupture and release of damage-associated molecular pattern molecules during ferroptosis.

PubMed ID: 38396301

DOI: 10.1038/s44318-024-00055-y

PubMed ID: 37198476

Title: Structural basis of NINJ1-mediated plasma membrane rupture in cell death.

PubMed ID: 37198476

DOI: 10.1038/s41586-023-05991-z

PubMed ID: 38614101

Title: NINJ1 mediates plasma membrane rupture by cutting and releasing membrane disks.

PubMed ID: 38614101

DOI: 10.1016/j.cell.2024.03.008

Sequence Information:

  • Length: 152
  • Mass: 16345
  • Checksum: FEACA99450187855
  • Sequence:
  • MDSGTEEYEL NGGLPPGTPG SPDASPARWG WRHGPINVNH YASKKSAAES MLDIALLMAN 
    ASQLKAVVEQ GPSFAFYVPL VVLISISLVL QIGVGVLLIF LVKYDLNNPA KHAKLDFLNN 
    LATGLVFIIV VVNIFITAFG VQKPLMDMAP QQ